Načítá se...
DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer
Aberrant DNA methylation is frequently detected in gastrointestinal tumors, and can therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal cancers (CRCs). Although colonoscopic screening remains the gold standard for CRC screening, this procedure is invasive, expens...
Uloženo v:
| Vydáno v: | Epigenomics |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4928499/ https://ncbi.nlm.nih.gov/pubmed/27102979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/epi-2015-0013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|